Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Nuclear Medicine|December 22, 2020
Prospective Correlation of Prognostic Immunohistochemical Markers With SUV and ADC Derived From Dedicated Hybrid Breast 18F-FDG PET/MRI in Women With Newly Diagnosed Breast CancerJanna Morawitz, Julian Kirchner, Ole Martin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2021
Determining the axillary nodal status with four current imaging modalities including <sup>18</sup>F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standardJanna Morawitz, Nils-Martin Bruckmann, Frederic Dietzel, et al.European Radiology|April 29, 2021
Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patientsNils Martin Bruckmann, Julian Kirchner, Lale Umutlu, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 3, 2024
Histopathologic, Molecular, and Clinical Profiling of Lymphoepithelioma-like Carcinoma of the BladderFlorestan Johannes Koll, Lillian Weers, Andreas Weigert, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 9, 2024
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical TherapyHelena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 26, 2020
Prospective evaluation of whole-body MRI and <sup>18</sup>F-FDG PET/MRI in N and M staging of primary breast cancer patientsNils Martin Bruckmann, Lino M Sawicki, Julian Kirchner, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2021
Comparison of nodal staging between CT, MRI, and [<sup>18</sup>F]-FDG PET/MRI in patients with newly diagnosed breast cancerJanna Morawitz, Nils-Martin Bruckmann, Frederic Dietzel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 2022
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor EntitiesNader Hirmas, Rainer Hamacher, Miriam Sraieb, et al.International Journal of Cancer|April 20, 2018
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomasHenning Reis, Kristan E van der Vos, Christian Niedworok, et al.Pageof 4